Literature DB >> 10688048

The response of growth hormone and prolactin of rats to hypoxia.

Y S Zhang1, J Z Du.   

Abstract

Effects of acute and chronic hypoxia on growth hormone (GH) and prolactin (PRL) of male rats were studied in a simulated hypobaric chambers at altitudes of 5 km (10.8% O2) and 7 km (7.2% O2), respectively. Acute hypoxia caused decreased plasma GH and increased pituitary GH content; both pituitary and plasma PRL contents at 2 h were decreased and plasma PRL level increased at 24 h. Prolonged exposure of hypoxia (5 km) to 25 days, both pituitary and plasma GH were obviously lower than control and pituitary PRL levels were decreased but plasma PRL increased markedly. The data presented suggest that long-term of hypoxia (10.8% O2) significantly suppresses body growth of rats and inhibits GH release and/or biosynthesis, which may in part correlate with decreased body weight gain; high circulating PRL concentration may be of significance in physiological adaptation to chronic hypoxia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688048     DOI: 10.1016/s0304-3940(99)00968-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Postnatal development in intermittent hypoxia enhances resistance to myocardial ischemia/reperfusion in male rats.

Authors:  Wei-Zhong Zhu; Jian-Wen Dong; Hai-Lei Ding; Huang-Tian Yang; Zhao-Nian Zhou
Journal:  Eur J Appl Physiol       Date:  2004-02-17       Impact factor: 3.078

2.  Exogenous growth hormone attenuates cognitive deficits induced by intermittent hypoxia in rats.

Authors:  R C Li; S Z Guo; M Raccurt; E Moudilou; G Morel; K R Brittian; D Gozal
Journal:  Neuroscience       Date:  2011-08-23       Impact factor: 3.590

3.  Neuroendocrine alterations in obese patients with sleep apnea syndrome.

Authors:  Fabio Lanfranco; Giovanna Motta; Marco Alessandro Minetto; Matteo Baldi; Marcella Balbo; Ezio Ghigo; Emanuela Arvat; Mauro Maccario
Journal:  Int J Endocrinol       Date:  2010-02-23       Impact factor: 3.257

4.  Growth hormone therapy during neonatal hypoxia in rats: body composition, bone mineral density, and insulin-like growth factor-1 expression.

Authors:  H Raff; E D Bruder; B Jankowski; M K Oaks; R J Colman
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

Review 5.  Growth hormone/insulin-like growth factor-I axis in obstructive sleep apnea syndrome: an update.

Authors:  F Lanfranco; G Motta; M A Minetto; E Ghigo; M Maccario
Journal:  J Endocrinol Invest       Date:  2010-03       Impact factor: 4.256

6.  Continuous positive airway pressure increases pulsatile growth hormone secretion and circulating insulin-like growth factor-1 in a time-dependent manner in men with obstructive sleep apnea: a randomized sham-controlled study.

Authors:  Camilla M Hoyos; Roo Killick; Daniel M Keenan; Robert C Baxter; Johannes D Veldhuis; Peter Y Liu
Journal:  Sleep       Date:  2014-04-01       Impact factor: 5.849

Review 7.  Metabolic consequences of sleep-disordered breathing.

Authors:  Jonathan Jun; Vsevolod Y Polotsky
Journal:  ILAR J       Date:  2009

8.  Prolactin selectively transported to cerebrospinal fluid from blood under hypoxic/ischemic conditions.

Authors:  Naoto Tani; Tomoya Ikeda; Miho Watanabe; Junko Toyomura; Akihiro Ohyama; Takaki Ishikawa
Journal:  PLoS One       Date:  2018-06-27       Impact factor: 3.240

9.  The correlation of serum/plasma IGF-1 concentrations with obstructive sleep apnea hypopnea syndrome: A meta-analysis and meta-regression.

Authors:  Jie He; Xiaoyan Li; Mi Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-31       Impact factor: 6.055

10.  Low level of IGF-1 in obesity may be related to obstructive sleep apnea syndrome.

Authors:  Ahmet Ursavas; Mehmet Karadag; Yesim Ozarda Ilcol; Ilker Ercan; Basak Burgazlioglu; Funda Coskun; R Oktay Gozu
Journal:  Lung       Date:  2007-08-27       Impact factor: 3.777

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.